1. Wu, Xiangbing, Cao, Wei, Wang, Xu, Wu, Yadi, Chen, Wantao. 2013. TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. In Molecular cancer, 12, 151. doi:10.1186/1476-4598-12-151. https://pubmed.ncbi.nlm.nih.gov/24289313/
2. Wu, Xiangbing, Wang, Rongyan, Jiao, Jiantong, Zhou, Leilei, Gong, Zhongjian. 2018. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer. In The international journal of biochemistry & cell biology, 104, 34-42. doi:10.1016/j.biocel.2018.08.016. https://pubmed.ncbi.nlm.nih.gov/30172723/
3. Zhang, Wenqing, Wu, Chenglong, Zhou, Kaili, Zhang, Xue, Deng, Dan. 2023. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker. In Frontiers in genetics, 13, 993438. doi:10.3389/fgene.2022.993438. https://pubmed.ncbi.nlm.nih.gov/36685895/
4. Hu, Jin-Wu, Yang, Zhang-Fu, Li, Jia, Fan, Jia, Huang, Xiao-Wu. 2019. TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection. In Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 52, 668-676. doi:10.1016/j.dld.2019.10.010. https://pubmed.ncbi.nlm.nih.gov/31822388/
5. Liu, Wei, Yu, Zai-Cheng, Cao, Wen-Feng, Ding, Fang, Liu, Zhi-Hua. . Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma. In World journal of gastroenterology, 12, 3929-32. doi:. https://pubmed.ncbi.nlm.nih.gov/16804985/
智鼠故事 
